Pharmaron supports ADC discovery and development with its fully integrated ADC platform. Through innovative design, we combine advanced antibody discovery, payload screening, and expert bioconjugation to address critical challenges such as solubility and Drug-Antibody Ratio (DAR). We specialize in delivering customized ADC solutions designed to meet the unique needs of our clients. Whether it’s standalone projects involving one or multiple services or comprehensive end-to-end programs, we ensure tailored support every step of the way.

Key Features of Pharmaron’s ADC Discovery Platform:

• Seamless integration of ADC discovery and development services.
• Expertise in antibody discovery, payload and linker design, and bioconjugation.
• Advanced efficacy testing with robust in vitro and animal models.
• Complete safety and DMPK assessments.
• Successfully delivered 340 ADCs in 2024.

Download our flyer to explore how Pharmaron advances ADC programs with scientific excellence.